• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate.

作者信息

Collinson M P, Tyrrel C J, Hutton C

出版信息

Calcif Tissue Int. 1994 Apr;54(4):327-8. doi: 10.1007/BF00295959.

DOI:10.1007/BF00295959
PMID:8062149
Abstract
摘要

相似文献

1
Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate.两名接受促黄体生成素释放激素类似物治疗前列腺癌的患者发生了骨质疏松症。
Calcif Tissue Int. 1994 Apr;54(4):327-8. doi: 10.1007/BF00295959.
2
Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.前列腺癌男性患者的雄激素剥夺与骨丢失率增加有关。
Prostate Cancer Prostatic Dis. 2002;5(4):304-10. doi: 10.1038/sj.pcan.4500599.
3
Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer.促性腺激素释放激素激动剂对前列腺癌患者骨代谢标志物及骨密度的影响。
Urology. 2004 Jul;64(1):128-31. doi: 10.1016/j.urology.2004.03.012.
4
Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awareness.戈舍瑞林植入治疗前列腺癌后垂体卒中的快速发作：需提高警惕
Intern Med J. 2001 Jul;31(5):313-4. doi: 10.1046/j.1445-5994.2001.00065.x.
5
A prospective, randomised study to compare goserelin acetate (Zoladex) versus cyproterone acetate (Cyprostat) versus a combination of the two in the treatment of metastatic prostatic carcinoma.一项前瞻性随机研究，比较醋酸戈舍瑞林（诺雷德）与醋酸环丙孕酮（色普龙）以及二者联合用药治疗转移性前列腺癌的效果。
Eur Urol. 1996;29(1):47-54. doi: 10.1159/000473717.
6
[A clinical study of decreased bone density in the patients treated with long-term luteinizing hormone releasing hormone analogue (LHRH-a)--the risk of iatrogenic osteoporosis due to treatment of carcinoma of prostate].长期使用促黄体生成素释放激素类似物（LHRH-a）治疗患者骨密度降低的临床研究——前列腺癌治疗所致医源性骨质疏松的风险
Nihon Hinyokika Gakkai Zasshi. 1998 Dec;89(12):961-6. doi: 10.5980/jpnjurol1989.89.961.
7
[Bone fracture receiving LH-RH agonists for prostatic cancer].[因前列腺癌接受促黄体生成素释放激素激动剂治疗导致的骨折]
Nihon Hinyokika Gakkai Zasshi. 2000 Jun;91(6):542-6. doi: 10.5980/jpnjurol1989.91.542.
8
Randomised crossover trial to assess the tolerability of LHRH analogue administration.评估促黄体生成素释放激素类似物给药耐受性的随机交叉试验。
Prostate Cancer Prostatic Dis. 2003;6(2):187-9. doi: 10.1038/sj.pcan.4500625.
9
Severe symptomatic osteoporosis in patients on androgen deprivation therapy for prostatic carcinoma.
Scand J Urol Nephrol. 2002;36(4):314-6. doi: 10.1080/003655902320248317.
10
Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.在雄激素剥夺治疗期间进行骨密度检测及开具预防或治疗骨质疏松症药物的医生诊疗行为。
Cancer. 2005 Jan 15;103(2):237-41. doi: 10.1002/cncr.20766.

引用本文的文献

1
Surgical Decompression of High-Grade Spinal Cord Compression from Hormone Refractory Metastatic Prostate Cancer.手术减压治疗激素难治性转移性前列腺癌引起的高分级脊髓压迫症
Neurosurgery. 2018 May 1;82(5):670-677. doi: 10.1093/neuros/nyx292.
2
Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment.老年癌症患者的跌倒：对患病率、致伤性跌倒及对癌症治疗影响的系统评价
Support Care Cancer. 2016 Oct;24(10):4459-69. doi: 10.1007/s00520-016-3342-8. Epub 2016 Jul 22.
3
The use of zoledronic acid in Japanese men with stage D2 prostate cancer.

本文引用的文献

1
Age-related changes of calcitonin secretion in females.女性降钙素分泌的年龄相关变化。
J Clin Endocrinol Metab. 1980 Mar;50(3):437-9. doi: 10.1210/jcem-50-3-437.
2
[Hormone studies in human senile osteoporosis].[人类老年性骨质疏松症的激素研究]
Minerva Med. 1981 Sep 8;72(32):2167-71.
3
[Osteoporosis in Klinefelter's syndrome Quantitative bone histological data in 5 cases and relationship with hormonal deficiency (author's transl)].克氏综合征中的骨质疏松症：5例定量骨组织学数据及其与激素缺乏的关系（作者译）
唑来膦酸在日本D2期前列腺癌男性患者中的应用。
Oncol Lett. 2010 Jan;1(1):13-16. doi: 10.3892/ol_00000002. Epub 2010 Jan 1.
4
Fracture risk in patients with prostate cancer on androgen deprivation therapy.接受雄激素剥夺治疗的前列腺癌患者的骨折风险
Osteoporos Int. 2005 Jun;16(6):707-11. doi: 10.1007/s00198-004-1799-7. Epub 2005 Feb 16.
5
Background to and management of treatment-related bone loss in prostate cancer.前列腺癌治疗相关骨质流失的背景与管理
Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002.
Nouv Presse Med. 1981 Feb 28;10(9):687-90.
4
Lower calcitonin levels in young hypogonadic men with osteoporosis.患有骨质疏松症的年轻性腺功能减退男性降钙素水平较低。
Horm Metab Res. 1983 Apr;15(4):206-7. doi: 10.1055/s-2007-1018673.
5
Osteoporosis and decline of gonadal function in the elderly male.老年男性骨质疏松症与性腺功能减退
Horm Res. 1984;19(1):18-22. doi: 10.1159/000179855.
6
Risk factors for spinal osteoporosis in men.男性脊柱骨质疏松症的危险因素。
Am J Med. 1983 Dec;75(6):977-83. doi: 10.1016/0002-9343(83)90878-1.
7
Osteoporosis in elderly men.老年男性骨质疏松症
Clin Endocrinol (Oxf). 1984 Sep;21(3):309-10. doi: 10.1111/j.1365-2265.1984.tb03474.x.
8
Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.雌激素对绝经后骨质疏松症患者钙吸收及血清维生素D代谢产物的影响
J Clin Endocrinol Metab. 1980 Dec;51(6):1359-64. doi: 10.1210/jcem-51-6-1359.
9
The syndrome of spinal osteoporosis.
Clin Endocrinol Metab. 1973 Jul;2(2):177-85. doi: 10.1016/s0300-595x(73)80038-6.
10
Testosterone and calcitonin plasma levels in hypogonadal osteoporotic young men.性腺功能减退的骨质疏松年轻男性的睾酮和降钙素血浆水平
J Endocrinol Invest. 1985 Aug;8(4):377-9. doi: 10.1007/BF03348518.